e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

Published

An Overview of Levamisole Hydrochloride with Immuno-Stimulant Activity

Published in April 2014 Issue 4 (Vol. 2, Issue 4, 2014)

An Overview of Levamisole Hydrochloride with Immuno-Stimulant Activity - Issue cover

Abstract

Levamisole, marketed as the hydrochloride salt under the trade name Ergamisol (R12564), is an anti helminthic and imminomodulator belonging to a class of synthetic imidazo-thiazole derivatives. It was discovered in 1966 at  Belgium's  Janssen pharmaceutica, where it was prepared initially in the form of its racemate called tetramisole. The two stereoisomersof tetramisole were subsequently synthesized, and the levorotatory isomer was given the name levamisole. Levamisole has been used in humans to treat parasitic worm infections, and has been studied in combination with other forms of chemotherapy for colon cancer, melanoma and head and neck cancer  In some of the leukemic cell line studies, both levamisole and tetramisole showed similar effect. Effective studies need to be undertaken to study the full potential of levamisole in Immunostimulation activities and immuno synergestic effect of Levamisole with combination to natural polysaccharides. Keywords-Levamisole, Immunostimulation, polysaccharide, Tetramisole

Authors (4)

Choudhury Ramesh Chandra

View all publications →

Chakraborty Jashabir

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Article Information

AJPHR204001

AJPHR-20-000001

2014-04-01

Article Impact

Views:2,451
Downloads:2,308

How to Cite

APA
MLA
Chicago
Harvard
Vancouver
IEEE
ACM
ACS
ABNT
Turabian
RIS (EndNote/Zotero/Mendeley)
BibTeX

Biswajit & Suvakanta & Ramesh, C. & Jashabir (2014). An Overview of Levamisole Hydrochloride with Immuno-Stimulant Activity. American Journal of Pharmacy and Health Research, 2(4), xx-xx. https://ajphr.com/articles/AJPHR204001

Article Actions